DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study, a Randomized, Placebo-controlled, Cross-over Study With Ertugliflozin in People With Type 2 Diabetes

NCT06983054 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: ertugliflozine
BEHAVIORAL: low salt diet
DRUG: placebo
BEHAVIORAL: high salt diet

Sponsor

Amsterdam UMC, location VUmc

Collaborators

[object Object]